FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2218197966> ?p ?o ?g. }

• W2218197966 endingPage "496" @default.
• W2218197966 startingPage "491" @default.
• W2218197966 abstract "The adjuvant treatment of early stage IA serous and clear cell carcinomas of the uterus is controversial. The aims of the study were to report on a single institution experience treating these high-risk early uterine cancers and to identify women who may be suitable for observation alone.A retrospective review of patients presenting from 2003 to 2013 with pathologic stage IA (International Federation of Gynecology and Obstetrics 2009) serous or clear cell uterine carcinoma was performed. Patient and disease characteristics, surgical staging, treatment details, and recurrence data were collected. Recurrence rates and 5-year actuarial estimates of recurrence free survival (RFS) were the primary outcomes of interest.A total of 77 patients with stage IA were identified. Median (range) follow-up was 34 (1-108) months. Staging lymphadenectomy was performed in 83%. Adjuvant treatment was given to 27 patients, whereas 50 underwent observation. There were 12 recurrences total, with the 5-year RFS 79% for the cohort, with no statistically significant difference between observation and adjuvant treatment. Only 4 patients received adjuvant chemotherapy and none recurred. In the observation cohort, the presence versus absence of myometrial invasion showed a trend to poorer 5-year RFS (75% vs 93%, P = 0.06).Observation seems to be a valid strategy in those patients with stage IA serous and clear cell carcinoma without myometrial invasion. The presence of any myometrial invasion may confer a higher risk of recurrence, although further studies are needed to determine the optimal adjuvant treatment regimen." @default.
• W2218197966 created "2016-06-24" @default.
• W2218197966 creator A5017024734 @default.
• W2218197966 creator A5025152932 @default.
• W2218197966 creator A5036116989 @default.
• W2218197966 creator A5046028077 @default.
• W2218197966 creator A5074984859 @default.
• W2218197966 date "2016-03-01" @default.
• W2218197966 modified "2023-09-26" @default.
• W2218197966 title "Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer" @default.
• W2218197966 cites W1852146320 @default.
• W2218197966 cites W1953918145 @default.
• W2218197966 cites W1967890742 @default.
• W2218197966 cites W1968836818 @default.
• W2218197966 cites W1995570458 @default.
• W2218197966 cites W1997079888 @default.
• W2218197966 cites W2000696573 @default.
• W2218197966 cites W2004577652 @default.
• W2218197966 cites W2006762762 @default.
• W2218197966 cites W2012090132 @default.
• W2218197966 cites W2027680551 @default.
• W2218197966 cites W2031222466 @default.
• W2218197966 cites W2036262139 @default.
• W2218197966 cites W2041440766 @default.
• W2218197966 cites W2046089575 @default.
• W2218197966 cites W2051937776 @default.
• W2218197966 cites W2052919443 @default.
• W2218197966 cites W2054354334 @default.
• W2218197966 cites W2065949107 @default.
• W2218197966 cites W2083556702 @default.
• W2218197966 cites W2089253083 @default.
• W2218197966 cites W2090235959 @default.
• W2218197966 cites W2092789117 @default.
• W2218197966 cites W2093627674 @default.
• W2218197966 cites W2098960933 @default.
• W2218197966 cites W2108556797 @default.
• W2218197966 cites W2118510249 @default.
• W2218197966 cites W2150537368 @default.
• W2218197966 cites W2163687756 @default.
• W2218197966 cites W2166074462 @default.
• W2218197966 doi "https://doi.org/10.1097/igc.0000000000000643" @default.
• W2218197966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26825823" @default.
• W2218197966 hasPublicationYear "2016" @default.
• W2218197966 type Work @default.
• W2218197966 sameAs 2218197966 @default.
• W2218197966 citedByCount "10" @default.
• W2218197966 countsByYear W22181979662017 @default.
• W2218197966 countsByYear W22181979662018 @default.
• W2218197966 countsByYear W22181979662019 @default.
• W2218197966 countsByYear W22181979662020 @default.
• W2218197966 countsByYear W22181979662021 @default.
• W2218197966 countsByYear W22181979662022 @default.
• W2218197966 countsByYear W22181979662023 @default.
• W2218197966 crossrefType "journal-article" @default.
• W2218197966 hasAuthorship W2218197966A5017024734 @default.
• W2218197966 hasAuthorship W2218197966A5025152932 @default.
• W2218197966 hasAuthorship W2218197966A5036116989 @default.
• W2218197966 hasAuthorship W2218197966A5046028077 @default.
• W2218197966 hasAuthorship W2218197966A5074984859 @default.
• W2218197966 hasConcept C121608353 @default.
• W2218197966 hasConcept C126322002 @default.
• W2218197966 hasConcept C141071460 @default.
• W2218197966 hasConcept C143998085 @default.
• W2218197966 hasConcept C146357865 @default.
• W2218197966 hasConcept C150173356 @default.
• W2218197966 hasConcept C151730666 @default.
• W2218197966 hasConcept C167135981 @default.
• W2218197966 hasConcept C2777088508 @default.
• W2218197966 hasConcept C2777632260 @default.
• W2218197966 hasConcept C2777863537 @default.
• W2218197966 hasConcept C2777982462 @default.
• W2218197966 hasConcept C2780427987 @default.
• W2218197966 hasConcept C2780824555 @default.
• W2218197966 hasConcept C2781413609 @default.
• W2218197966 hasConcept C71924100 @default.
• W2218197966 hasConcept C72563966 @default.
• W2218197966 hasConcept C86803240 @default.
• W2218197966 hasConceptScore W2218197966C121608353 @default.
• W2218197966 hasConceptScore W2218197966C126322002 @default.
• W2218197966 hasConceptScore W2218197966C141071460 @default.
• W2218197966 hasConceptScore W2218197966C143998085 @default.
• W2218197966 hasConceptScore W2218197966C146357865 @default.
• W2218197966 hasConceptScore W2218197966C150173356 @default.
• W2218197966 hasConceptScore W2218197966C151730666 @default.
• W2218197966 hasConceptScore W2218197966C167135981 @default.
• W2218197966 hasConceptScore W2218197966C2777088508 @default.
• W2218197966 hasConceptScore W2218197966C2777632260 @default.
• W2218197966 hasConceptScore W2218197966C2777863537 @default.
• W2218197966 hasConceptScore W2218197966C2777982462 @default.
• W2218197966 hasConceptScore W2218197966C2780427987 @default.
• W2218197966 hasConceptScore W2218197966C2780824555 @default.
• W2218197966 hasConceptScore W2218197966C2781413609 @default.
• W2218197966 hasConceptScore W2218197966C71924100 @default.
• W2218197966 hasConceptScore W2218197966C72563966 @default.
• W2218197966 hasConceptScore W2218197966C86803240 @default.
• W2218197966 hasIssue "3" @default.
• W2218197966 hasLocation W22181979661 @default.
• W2218197966 hasLocation W22181979662 @default.

• next